Halozyme Therapeutics Statistics
Total Valuation
HALO has a market cap or net worth of $7.11 billion. The enterprise value is $8.05 billion.
Market Cap | 7.11B |
Enterprise Value | 8.05B |
Important Dates
The last earnings date was Tuesday, February 18, 2025, after market close.
Earnings Date | Feb 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HALO has 123.15 million shares outstanding. The number of shares has decreased by -3.56% in one year.
Current Share Class | 123.15M |
Shares Outstanding | 123.15M |
Shares Change (YoY) | -3.56% |
Shares Change (QoQ) | -0.89% |
Owned by Insiders (%) | 1.09% |
Owned by Institutions (%) | 101.45% |
Float | 121.75M |
Valuation Ratios
The trailing PE ratio is 16.84 and the forward PE ratio is 11.72.
PE Ratio | 16.84 |
Forward PE | 11.72 |
PS Ratio | 7.21 |
Forward PS | 6.15 |
PB Ratio | 19.55 |
P/TBV Ratio | n/a |
P/FCF Ratio | 15.18 |
P/OCF Ratio | 14.85 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.89, with an EV/FCF ratio of 17.19.
EV / Earnings | 18.13 |
EV / Sales | 7.93 |
EV / EBITDA | 12.89 |
EV / EBIT | 14.60 |
EV / FCF | 17.19 |
Financial Position
The company has a current ratio of 7.80, with a Debt / Equity ratio of 4.22.
Current Ratio | 7.80 |
Quick Ratio | 6.50 |
Debt / Equity | 4.22 |
Debt / EBITDA | 2.43 |
Debt / FCF | 3.28 |
Interest Coverage | 30.48 |
Financial Efficiency
Return on equity (ROE) is 198.42% and return on invested capital (ROIC) is 19.61%.
Return on Equity (ROE) | 198.42% |
Return on Assets (ROA) | 18.16% |
Return on Invested Capital (ROIC) | 19.61% |
Return on Capital Employed (ROCE) | 28.66% |
Revenue Per Employee | $2.90M |
Profits Per Employee | $1.27M |
Employee Count | 350 |
Asset Turnover | 0.53 |
Inventory Turnover | 1.77 |
Taxes
In the past 12 months, HALO has paid $113.04 million in taxes.
Income Tax | 113.04M |
Effective Tax Rate | 20.29% |
Stock Price Statistics
The stock price has increased by +60.42% in the last 52 weeks. The beta is 1.25, so HALO's price volatility has been higher than the market average.
Beta (5Y) | 1.25 |
52-Week Price Change | +60.42% |
50-Day Moving Average | 53.04 |
200-Day Moving Average | 53.09 |
Relative Strength Index (RSI) | 62.94 |
Average Volume (20 Days) | 1,140,159 |
Short Selling Information
The latest short interest is 9.06 million, so 7.35% of the outstanding shares have been sold short.
Short Interest | 9.06M |
Short Previous Month | 9.41M |
Short % of Shares Out | 7.35% |
Short % of Float | 7.44% |
Short Ratio (days to cover) | 6.59 |
Income Statement
In the last 12 months, HALO had revenue of $1.02 billion and earned $444.09 million in profits. Earnings per share was $3.43.
Revenue | 1.02B |
Gross Profit | 776.86M |
Operating Income | 551.48M |
Pretax Income | 416.71M |
Net Income | 444.09M |
EBITDA | 624.59M |
EBIT | 551.48M |
Earnings Per Share (EPS) | $3.43 |
Balance Sheet
The company has $596.07 million in cash and $1.54 billion in debt, giving a net cash position of -$940.43 million or -$7.64 per share.
Cash & Cash Equivalents | 596.07M |
Total Debt | 1.54B |
Net Cash | -940.43M |
Net Cash Per Share | -$7.64 |
Equity (Book Value) | 363.82M |
Book Value Per Share | 2.95 |
Working Capital | 946.24M |
Cash Flow
In the last 12 months, operating cash flow was $479.06 million and capital expenditures -$10.70 million, giving a free cash flow of $468.37 million.
Operating Cash Flow | 479.06M |
Capital Expenditures | -10.70M |
Free Cash Flow | 468.37M |
FCF Per Share | $3.80 |
Margins
Gross margin is 76.51%, with operating and profit margins of 54.32% and 43.74%.
Gross Margin | 76.51% |
Operating Margin | 54.32% |
Pretax Margin | 54.87% |
Profit Margin | 43.74% |
EBITDA Margin | 61.52% |
EBIT Margin | 54.32% |
FCF Margin | 46.13% |
Dividends & Yields
HALO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 3.56% |
Shareholder Yield | 3.56% |
Earnings Yield | 6.24% |
FCF Yield | 6.59% |
Analyst Forecast
The average price target for HALO is $62.78, which is 8.71% higher than the current price. The consensus rating is "Buy".
Price Target | $62.78 |
Price Target Difference | 8.71% |
Analyst Consensus | Buy |
Analyst Count | 9 |
Revenue Growth Forecast (5Y) | 12.96% |
EPS Growth Forecast (5Y) | 26.79% |
Stock Splits
The last stock split was on December 10, 2003. It was a forward split with a ratio of 4.275:1.
Last Split Date | Dec 10, 2003 |
Split Type | Forward |
Split Ratio | 4.275:1 |
Scores
HALO has an Altman Z-Score of 4.31 and a Piotroski F-Score of 7.
Altman Z-Score | 4.31 |
Piotroski F-Score | 7 |